The present application relates to a compositions and methods comprising or expressing a hevamine A-related MoMo30 protein from Momordica balsamina. The MoMo30 protein is about 30 kDa in size, is stable after being autoclaved at 120° C. for 30 min, resists proteolytic cleavage by trypsin, exhibits mannose-sensitive binding to HIV gp120, exhibits hemagglutinin and chitinase activity, is capable of activating and stimulating T cell proliferation, is capable of preventing infection by HIV-1 or alleviating symptoms in an HIV-1 infected patients, and comprises an amino acid sequence of SEQ ID NO: 4. The MoMo30 protein and/or a nucleic acid encoding the same may be used in methods for preventing or treating microbial infections by HIV, SARS-CoV-2 and other enveloped viruses, as well as other microorganisms comprising cell surface proteins containing glycan residues, such as mannose.

A consumer product composition that includes a population of delivery particles, where the delivery particles include a core and a polymer wall surrounding the core, the polymer wall being derived from (meth)acrylate monomers and at least one free radical initiator, and the core including a benefit agent such as perfume, where the core and the polymer wall are present in a weight ratio of from about 95:5 to about 99.5:0.5, and where the initiator is typically used at a certain level. Related methods of making and using such consumer product compositions.

Provided are a biodegradable sheet with antiviral properties, a manufacturing method thereof, and the use thereof. The biodegradable sheet comprises: a biodegradable polymer resin consisting of a polylactic acid-based polymer; or a composite degradable polymer resin comprising of a biodegradable resin and a petrochemical resin; and particles of an inorganic antiviral agent or aggregated composite particles of at least two inorganic antiviral agents incorporated into the biodegradable sheet so that the inorganic antiviral agent can be dispersed with a particle size of 100 to 900 nm.

The present disclosure describes chemical blends and methods of using those blends for multipurpose environmental disinfection of objects and surfaces. The disclosed chemical blends composition comprising stabilized chlorine dioxide; a quaternary ammonium salt; ammonium phosphate; nonionized ammonia; buffer, surfactant, stabilizer; and water. The composition is configured to inactivate the full range of environmental and pathogenic organisms, including amoeba, bacterial spores, vegetative bacteria, fungi, viruses, parasites (eggs and oocysts) and toxic microbial products.

The present disclosure describes chemical blends and methods of using those blends for multipurpose environmental disinfection of objects and surfaces. The disclosed chemical blends composition comprising stabilized chlorine dioxide; a quaternary ammonium salt; ammonium phosphate; nonionized ammonia; buffer, surfactant, stabilizer; and water. The composition is configured to inactivate the full range of environmental and pathogenic organisms, including amoeba, bacterial spores, vegetative bacteria, fungi, viruses, parasites (eggs and oocysts) and toxic microbial products.

Disclosed are micronutrient chelate compositions and methods that provide nutrients to a plant to improve growth while controlling pathogens, such as Candidatus Liberibacter asiaticus the causal pathogen for citrus greening disease, by improving plant health through the enhancement of beneficial microbial populations resident in the plants phloem. The chelate compositions include a combination of a metal, such as iron, and a derivative of a chelating agent such as EDDHA or HBED. The chelate formulations can either be a dry formulation or liquid formulation that is dispersed in a selected amount of water and applied to the foliage of a plant and/or applied to the soil proximal to the plant rhizosphere.

The present invention is a liquid detergent composition for textile products containing (a) a surfactant, (b) an alcohol with 10 or more and 16 or less carbons and (c) an antibacterial compound having an aromatic ring (excluding quaternary ammonium salts).

Antimicrobial compositions and methods of use thereof are described. The antimicrobial compositions have an acid system, an anionic surfactant system and 2-phenoxyethanol and/or a fragrance. The acid system includes at least 30 wt % of octanoic acid and a secondary acid. The anionic surfactant system includes at least 60 wt % of octyl sulfate and a secondary surfactant having a moiety with a carbon chain length with at least ten carbon atoms. The antimicrobial composition has a pH of from about 1.5 to about 5 as measured at 20° C.

A method of preparing iron oxide nanoparticles using an herbal mixture comprising Capparis spinosa, Cichorium intybus, Solanum nigrum, Cassia occidentalis, Terminalia arjuna, Achillea millefolium, and Tamarix gallica. The method produces crystalline γ-Fe.sub.2O.sub.3 nanoparticles which are superparamagnetic. The iron oxide nanoparticles are used in a method of killing or inhibiting the growth of a bacteria and/or fungus, particularly in the form of a biofilm. The nanoparticles are also used in a method of treating colon cancer.

Antimicrobial compositions for killing or deactivating microbes, such as viruses, bacteria, or fungi, include metal nanoparticles, a carrier, and a plurality of metal nanoparticles. The nanoparticles can be selected to have a particle size and particle size distribution to selectively and preferentially kill one of a virus, a bacterium, or a fungus. Antiviral compositions can include nanoparticles having a particle size of 8 nm or less, 1-7 nm, 2-6.5 nm, or 3-6 nm. Antibacterial compositions can include nanoparticles having a particle size of 3-14 nm, 5-13 nm, 7-12 nm, or 8-10 nm. Antifungal compositions can include nanoparticles having a particle size of 9-20 nm, 10-18 nm, 11-16 nm, or 12-15 nm.